Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2003
11/19/2003CN1457339A Chemokine receptor binding heterocyclic compounds
11/19/2003CN1457337A Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
11/19/2003CN1457261A Method and compositions for prevention or treatment of cancer
11/19/2003CN1457258A Methods of treating viral diseases with IL-18 and IL-18 compositions
11/19/2003CN1457256A Eye drops
11/19/2003CN1457255A Compositions of biochemical compounds involved in bioenergy metabolism of cells and method of use
11/19/2003CN1457253A External application for enhancing skin permeability of active components therein
11/19/2003CN1456574A Preparing method for extracting polypeptide antibiotics from silkworm
11/19/2003CN1456568A Organic salts of parabuxinidine-D, their preparations and uses
11/19/2003CN1456561A Preparations of leucovorin and its carbonates
11/19/2003CN1456560A 1-aryl beta-carboline and thio-similities, their preparations and uses in medicines
11/19/2003CN1456556A Di (5-formylfurfuryl) ether derivatives, preparations thereof and their uses in medicines
11/19/2003CN1456548A Process for extracting leonuridine from fresh motherwort and leonuridine preparation
11/19/2003CN1456341A Lung clearing oral liquid preparation for treating viral pneumonia in Children and preparing method thereof
11/19/2003CN1456336A Rhodiola root powdery injection and its preparation
11/19/2003CN1456333A Capsules against thrombus and preparation thereof
11/19/2003CN1456276A Medicines for treating thyroma and hydatoncus
11/19/2003CN1456275A Medicines for treating Hashimoto's thyroncus
11/19/2003CN1456274A Medicine for treating endocrine infiltrative exophthalmos
11/19/2003CN1456178A External applied medicine for curing burn and preparing method thereof
11/19/2003CN1456172A Healthy vitamin nutrient solution
11/19/2003CN1456170A External applied medicine composition containing vitamin š�*
11/19/2003CN1456169A Preparation with haw leaf extractive as main effect composition
11/19/2003CN1456168A Anti-fatigue formulating prescription
11/19/2003CN1456167A Artificial tear containing phosphatide and preparing method thereof
11/19/2003CN1456166A Instant biliary ascariasis preparation
11/19/2003CN1456165A Method for increasing solubility of parabuxinidine-D injection
11/19/2003CN1456164A Parabuxinidine pills and preparation thereof
11/19/2003CN1456163A Oral medicine of leucovocin calcium and its preparing method
11/19/2003CN1456162A Injection of leucovorin calcium and its preparing method
11/19/2003CN1456161A Eye gel for atropine sulfate
11/19/2003CN1456160A Preparation of composite motidine dispersant pills
11/19/2003CN1456159A Fluconazole injection and its preparing process
11/19/2003CN1456158A Eye drops of fluconazole
11/19/2003CN1456157A Ophthalmic gel of L-ofloxacin
11/19/2003CN1456156A Ophthalmic gel of marticarpine
11/19/2003CN1456155A Mesilate phentolamine suppository and its preparation
11/19/2003CN1456154A Method for curing sepsis
11/19/2003CN1456153A Preparing method for Xiatianwu alkaloids
11/19/2003CN1456152A Lyophilized preparation of civeleth sodium
11/19/2003CN1456151A Preparing method for sustained releasing huperzine preparation
11/19/2003CN1456150A Garlicin injection preparation
11/19/2003CN1456148A Use of enlerogastric dynamic medicine in preparation of colonic orientation medicinal composition
11/19/2003CN1128224C Process for production of lipstation and tetraphydrolipstatin
11/19/2003CN1128223C Production process of compound L-amino acid calcium
11/19/2003CN1128149C 6,9-disubsituted 2-[trans-(4-aminocyclohexyl)amino]purines
11/19/2003CN1128147C 3-oxo-2(H)-1,2,4-triazine deriatives as ligands of 5HT1A receptors
11/19/2003CN1128144C Indane-1-alcohol compound, its preparation method and medical composition containing same
11/19/2003CN1128142C Novel substituted dipolymer compounds, prepn. method therefor, pharmaceutical compositions contg. same
11/19/2003CN1128139C New piperazine derivatives and its prepn.
11/19/2003CN1127984C Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing antitumor agent and hydroxamic acid derivative
11/19/2003CN1127976C Exterior-applied Chinese-medicinal pill for treatnig diarrhea
11/19/2003CN1127970C Ointment for treating burn and its preparing process
11/19/2003CN1127966C 'Hehe' ointment and its preparing process
11/19/2003CN1127961C Exterior-applied medicine for treatnig dermatopathy and its preparing process
11/19/2003CN1127960C Eyesight improving medicine liquid
11/19/2003CN1127959C Application of isopropylfuran in preparing hepatitis B virus resisting medicine
11/19/2003CN1127958C Use of baicalin flavone in treating depression
11/19/2003CN1127957C Exterior-applied medicine for treating chilblains
11/19/2003CN1127956C Medicine for curing and operating purpose and its preparing method
11/19/2003CN1127955C Medicine for treating immune relative disease of anterior chamber and surface of eye
11/19/2003CN1127954C Use of R(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4- piperidinemethanol for treatment of sleep disorders
11/19/2003CN1127953C Medicine for delaying chronic kidney hypofunction
11/19/2003CN1127952C Anticancer medicine composition
11/19/2003CN1127951C Application of rhein in treating insulin resistance
11/19/2003CN1127950C Antirheumatic agents
11/19/2003CN1127949C Composite coenzyme Q10 health nutriment
11/18/2003US6649811 Use of nimesulide for the preparation of a pharmaceutical formulation for treating a neurodegenerative condition
11/18/2003US6649797 Contacting protein with a compound that is capable of stable reversible binding with basic amino acid residues of nuclear localization signal of protein for inactivating a nuclear localization signal of a protein
11/18/2003US6649763 Optically active quinoline carboxylic acid derivatives with 7-pyrrolidine substituents causing optical activity and a process for the preparation thereof
11/18/2003US6649762 Crystal modification C of 8-cyano-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihyro-4-oxo-3-quinoline carboxylic
11/18/2003US6649756 Process improvement in the preparation of (4r, 5s, 6s)-3-[[(2r,3r)-2-[[[(s)-2-amino-3-methyl-1-oxobutyl]amino]methyl]tetrahydro-3-furanyl]thio]-6-[(r)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
11/18/2003US6649755 Process for preparing acarbose with high purity
11/18/2003US6649747 Composition and method for diagnosing auto-immune hepatitis
11/18/2003US6649745 Oligospirostanoside, pharmaceutical composition containing novel oligospirostanoside and method for immunomodulation using said oligospirostanoside
11/18/2003US6649660 Composition for treatment of infections of humans and animals
11/18/2003US6649659 Atovaquone pharmaceutical compositions
11/18/2003US6649658 (−)-Verbenone derivatives
11/18/2003US6649657 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
11/18/2003US6649655 11β-fluoro 15β-hydroxy PGF2α analogs as FP receptor antagonists
11/18/2003US6649654 Methods for identifying and using IKK inhibitors
11/18/2003US6649653 15-fluoro prostaglandins as ocular hypotensives
11/18/2003US6649652 Prodrugs for antimicrobial amidines
11/18/2003US6649651 AIDS; human T-cell lymphoma/leukemia virus or lymphadenopathy associated virus treatment
11/18/2003US6649650 Herbal chemical composition for the treatment of cancer
11/18/2003US6649649 Method of treating colonic adenomas
11/18/2003US6649648 Administering 1-chroman, 1-thiochroman or quinoline derivative as anticarcinogenic or antimetastasis agent
11/18/2003US6649645 Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia
11/18/2003US6649644 Method of treating HIV infection by combined use of a cytotoxic agent and a non-nucleoside reverse transcriptase inhibitor
11/18/2003US6649641 Glucagon antagonists/inverse agonists
11/18/2003US6649640 Isoxazole compositions useful as inhibitors of ERK
11/18/2003US6649639 Inhibit or block the biological activity of the picornaviral 3C protease.
11/18/2003US6649637 Inhibiting intracellular replication of a parasite that possesses endogenous mitogen activated protein parasite that possesses endogenous mitogen activated protein kinase activity, by contact with a substituted imidazole
11/18/2003US6649636 Cyclooxygenase inhibitors
11/18/2003US6649634 Use in treating diabetes, hyperglycemia, hypercholesterolemia, hypertension, hyperinsulinemias, hyperlipidemia, atherosclerosis and myocardial ischemia in mammals
11/18/2003US6649633 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
11/18/2003US6649631 Administering pyridine derivative
11/18/2003US6649629 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/18/2003US6649628 Retinopathy, neuropathy and nephropathy treatment; antidiabetic agents
11/18/2003US6649627 N-Substituted with 1- (pyrid-2-yl)-piperidine-4-yl radical; gastrointestinal and psychological disorder treatment; antidiabetic tocolytic, and antidepressant agents; irritable bowel syndrome, glaucoma and dysmenorrhoea